Question

3．AIDS researchers say they still have much work to do on a vaccine （疫苗）against HIV．But the first reports of some success have raised hopes．（33）C 
The study was designed to test for two abilities．One was the ability of the vaccine to prevent HIV infections．The other was its ability to reduce the amount of virus in the blood of people who became infected during the study．
Volunteers received vaccinations over a period of six months and were tested for HIV for an additional three years．The study began in 2003．It was the largest AIDS vaccine trial yet．（34）F    Half received the vaccine．The other half received a placeho，an inactive substance （物質(zhì)）．The volunteers did not know which they were getting．
Seventy-four people in the placeho group became infected during the study．（35）D  Doctor Supachai Rerks-Ngarm，who led the study for the Thai Ministry of Public Health，called it a scientific breakthrough．
The National Institutes of Health also took part．Doctor Anthony Fauci at NIH called the findings an important step forward．（36）G But he also said additional research was needed to better understand how the vaccine reduced the risk in those individuals．
The vaccine did not lower the amount of virus in the blood of volunteers who became infected during the study．The study was based on versions of HIV commonly found in Thailand．The volunteers received a combination of two vaccines．（37）A  The second，or booster，vaccine was developed by VaxGen．The nonprofit group Global Solution for Infectious Diseases now has rights to it．
Neither vaccine had been successful by itself when tested earlier．More detailed results of the study are expected to be presented at an AIDS vaccine conference in Paris next month．

A．The first，or prime，vaccine came from the Sanofi Pasteur company．
B．The AIDS vaccine raises hopes for those who get infected and will defeat the disease thoroughly．
C．Scientists say an experimental vaccine reduced the risk of infection in humans by thirsty-one percent and was safe．
D．The researchers say that was compared with only fifty-one of those who received the vaccine．
E．AIDS is a very serious phenomenon in Thailand．
F．It involved more than sixteen thousand adults in Thailand．
G．He said it represented the first time an investigational HIV vaccine had shown some ability to prevent infection．

Answer 1

分析 本文講到艾滋病研究人員認(rèn)為，關(guān)于對(duì)抗HIV的疫苗，他們?nèi)匀挥性S多工作要做．科學(xué)家說(shuō)一種實(shí)驗(yàn)性疫苗降低了人類感染的風(fēng)險(xiǎn)，是很安全的．之后對(duì)該疫苗進(jìn)行了研究．

解答 CFDGA
33．C聯(lián)系下文題．根據(jù)后文The study was designed to test for two abilities．提到了一個(gè)實(shí)驗(yàn)研究．C項(xiàng)：Scientists say an experimental vaccine reduced the risk of infection in humans by thirsty-one percent and was safe．科學(xué)家說(shuō)一種實(shí)驗(yàn)性疫苗降低了人類感染的風(fēng)險(xiǎn)，是很安全的．符合文意，故選C．
34．F語(yǔ)境辨析題．根據(jù)上文It was the largest AIDS vaccine trial yet．可知這是迄今為止規(guī)模最大的艾滋病疫苗試驗(yàn)．F項(xiàng)：It involved more than sixteen thousand adults in Thailand．泰國(guó)有一萬(wàn)六千多名成年人參與其中．符合文意，故選F．
35．D文章銜接題．根據(jù)上文Seventy-four people in the placeho group became infected during the study．可知研究期間，有74%的人被感染．D項(xiàng)：The researchers say that was compared with only fifty-one of those who received the vaccine．研究人員說(shuō)，這是與接受疫苗的51%的人相比．符合文意，故選D．
36．G聯(lián)系下文題．根據(jù)下文But he also said additional research was needed to better understand how the vaccine reduced the risk in those individuals．可知但是他也說(shuō)需要更多的研究來(lái)更好地了解疫苗是如何降低這些人的風(fēng)險(xiǎn)的．G項(xiàng)：He said it represented the first time an investigational HIV vaccine had shown some ability to prevent infection．他說(shuō)，這是首次研究性HIV疫苗顯示了某種預(yù)防感染的能力．符合文意，故選G．
37．A文章銜接題．根據(jù)后文The second（第二種），or booster，…可知A項(xiàng)：The first，or prime，vaccine came from the Sanofi Pasteur company．第一種疫苗，或者是最早的疫苗來(lái)自賽諾菲-巴斯德公司．符合文意，故選A．

點(diǎn)評(píng) 在答題中，應(yīng)首先略讀各小題，了解一下大致意思，然后把幾個(gè)選項(xiàng)含義理解透，尤其注意意思相近，表達(dá)有交叉的選項(xiàng)之間的區(qū)別．特別注意文章上下文的串聯(lián)結(jié)構(gòu)．然后再細(xì)讀題目，選出正確答案．答題時(shí)可以把含義相近的幾個(gè)選項(xiàng)輪流填入同一處位置，反復(fù)閱讀，反復(fù)體會(huì)，找出最佳選項(xiàng)，對(duì)于實(shí)在沒(méi)有把握的小題可以留待最后完成．